|
⚲
|
| Alseres Pharmaceuticals Inc /DE | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000094784 |
| Sale | 2009-11-04 ($1.0 M Offered, $1.0 M Sold) |
| Fund | |
| Phone | 5084972360 |
| Address | 239 South Street Hopkinton, 01748 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| William Guinness | |
| Michael Mullen | |
| Gary Frashier | |
| John Preston | |
| Peter Savas | |
| Kenneth Rice Jr | |
| Mark Pykett | |
| Henry Brem | |
| Robert Langer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Asymmetria Investors III, LLC - Aeromed (PS)
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - AFFF (PS)
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - EGAP Fund II Add-On (PS)
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - Forte (PS)
✚
|
0.0 | |
|
A-TEW-13-Fund, a series of AX-JaGi-Funds, LLC
✚
|
0.0 | |
|
Athayde Amanda
✚
|
0.0 | |
|
Athens Buligo LP
✚
|
0.0 | |
|
Atkinson Robert D
✚
|
0.0 | |
|
ATL 105 LLC
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - ACI Fund III (PS)
✚
|
0.0 |